Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |